Search Results - "NAKANE, TAMIKO"

  • Showing 1 - 6 results of 6
Refine Results
  1. 1

    Antibacterial activity of cefozopran, a new cephem antibiotic by Nakane, Tamiko, Mitsuhashi, Susumu

    Published in CHEMOTHERAPY (1993)
    “…The antibacterial activity of a new cephem antibiotic, cefozopran (CZOP), was compared with those of cefclidin (CFCL), cefpirome (CPR), cefepime (CFPM) and…”
    Get full text
    Journal Article
  2. 2

    Antibacterial activity of loracarbef, a new carbacephem antibiotic by Nakane, Tamiko, Inoue, Kunio, Mitsuhashi, Susumu

    Published in CHEMOTHERAPY (1993)
    “…The antibacterial activity of a new oral carbacephem antibiotic, loracarbef (LCBF), was compared with those of cefaclor (CCL), cefdinir (CFDN) and cefprozil…”
    Get full text
    Journal Article
  3. 3

    IN VITRO ANTIBACTERIAL ACTIVITY AND B-LACTAMASE STABILITY OF CEFOTIAM HEXETIL by NAKANE, TAMIKO, INOUE, MATSUHISA, FUJII, TADASHI, MITSUHASHI, SUSUMU

    Published in CHEMOTHERAPY (1988)
    “…Cefotiam hexetil (CTM-HE), an orally active ester derivative, is a new cefotiam (CMT) pro-drug. We compared the in vitro antibacterial activity and β-lactamase…”
    Get full text
    Journal Article
  4. 4

    IN VITRO AND IN VIVO ANTIBACTERIAL ACTIVITY OF CARUMONAM by INOUE, KUNIO, NAKANE, TAMIKO, MATSUDA, KOUJI, INOUE, MATSUHISA, MITSUHASHI, SUSUMU

    Published in CHEMOTHERAPY (1987)
    “…The in vitro and in vivo antibacterial activity of carumonam (CRMN) against both Gram-positive and Gram-negative clinical isolates was studied in comparison…”
    Get full text
    Journal Article
  5. 5

    IN VITRO AND IN VIVO ANTIBACTERIAL ACTIVITY OF CEFUROXIME AXETIL by INOUE, KUNIO, NAKANE, TAMIKO, OKAMOTO, SEIKI, MITSUHASHI, SUSUMU, INOUE, MATSUHISA

    Published in CHEMOTHERAPY (1986)
    “…The in vitro and in vivo antibacterial activites of cefuroxime axetil (CXM-AX), the 1-acetoxyethyl ester of cefuroxime (CXM), were investigated in comparison…”
    Get full text
    Journal Article
  6. 6

    In-vitro evaluation of the four beta-lactamase inhibitors: BRL42715, clavulanic acid, sulbactam, and tazobactam by Muratani, T, Yokota, E, Nakane, T, Inoue, E, Mitsuhashi, S

    Published in Journal of antimicrobial chemotherapy (01-09-1993)
    “…The in-vitro synergic activities of BRL42715, a new beta-lactamase inhibitor, clavulanic acid, sulbactam, and tazobactam combined with ampicillin,…”
    Get more information
    Journal Article